Last reviewed · How we verify
MAK
MAK is a traditional Ayurvedic herbal formulation that is proposed to support overall wellness and balance according to Ayurvedic principles.
MAK is a traditional Ayurvedic herbal formulation that is proposed to support overall wellness and balance according to Ayurvedic principles. Used for General wellness and rejuvenation (Ayurvedic indication).
At a glance
| Generic name | MAK |
|---|---|
| Sponsor | National Center for Complementary and Integrative Health (NCCIH) |
| Modality | Small molecule |
| Therapeutic area | Complementary and Integrative Health |
| Phase | FDA-approved |
Mechanism of action
MAK (Maharishi Amrit Kalash) is a polyherbal Ayurvedic preparation consisting of multiple plant-derived ingredients. It is marketed as an adaptogenic and antioxidant formulation intended to promote general health and longevity. The specific molecular mechanisms have not been rigorously characterized in conventional pharmaceutical terms.
Approved indications
- General wellness and health promotion (Ayurvedic indication)
Common side effects
Key clinical trials
- Self-Efficacy and Academic Burnout Among Sports Science Undergraduates in Indonesia
- Evaluation of an Ayurvedic Herbal Compound Compared to Vitamins C+E and Placebo on Vascular Function in High-Risk Subjects (NA)
- Cerebral and Peripheral Near Infrared Spectroscopy Monitoring in Low and High Flow Anaesthesia in Pediatric (NA)
- Attentional Focus Instructions and Conscious Movement Processing in Older Adults
- Clinical Study of MAK Immune Cells in the Treatment of PHC (NA)
- Umbilical Cord Blood Derived MAK Immune Cells Combined With Standard Second-Line Treatments for Hepatobiliary and Pancreatic Malignancies (PHASE1)
- Effects of TIVA and Inhalation Anesthesia on Oxidative Stress Factors During Hypotensive Anesthesia (NA)
- Different Low-flow Sevoflurane Anesthesia Techniques
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- MAK CI brief — competitive landscape report
- MAK updates RSS · CI watch RSS
- National Center for Complementary and Integrative Health (NCCIH) portfolio CI